Article
Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 May 2024
Ng Jin, Cai Ling, Girard Luc, Prall Owen W J, Rajan Neeha, Khoo Christine, Batrouney Ahida, Byrne David J, Boyd Danielle K, Kersbergen Ariena J, Christie Michael, Minna John D, Burr Marian L, Sutherland Kate D
Abstract excerpt
PURPOSE: The classification of small cell lung cancer (SCLC) into distinct molecular subtypes defined by ASCL1, NEUROD1, POU2F3, or YAP1 (SCLC-A, -N, -P, or -Y) expression, paves the way for a personalized treatment approach. However, the existence of a distinct YAP1-expressing SCLC subtype remains controversial. EXPERIMENTAL DESIGN: To better understand YAP1-expressing SCLC, the mutational landscape of human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
